South Korean Broadcaster 풍자 (Pungja) Shares Struggles with Weight Loss Medication and Potential Rebound Weight Gain
South Korean television personality 풍자 (Pungja), whose real name is Park Sun-young, has publicly discussed the challenges she’s facing during her weight loss journey, including potential side effects from medication and concerns about regaining lost weight. The broadcaster, who previously announced a 28kg (approximately 61.7 pounds) weight loss, detailed her experiences in a recent video posted on her YouTube channel, ‘풍자테레비’ (Pungja TV). This comes amid growing public interest and scrutiny surrounding the use of weight loss drugs like Wegovy and Saxenda in South Korea.
In the video, posted on March 9th, 풍자 described experiencing intense hunger despite being in a cold, remote camping location at -18°C (0°F). She attributed this increased appetite to potential side effects or the beginning of a “yo-yo effect” – the cyclical pattern of losing and regaining weight – often associated with rapid weight loss and certain medications. The video, titled ‘영하 18도 눈 쌓인 장박지에서 직화구이’ (Direct Grilled Fish in a Snow-Covered Long-Term Camping Spot at -18°C), showed 풍자 enjoying a meal of grilled fish, stew, and a traditional Korean alcoholic beverage, highlighting the difficulty of resisting cravings.
The Rise of GLP-1 Receptor Agonists in South Korea
풍자 had previously revealed that she was using medications like Wegovy and Saxenda to aid her weight loss. These drugs belong to a class of medications called GLP-1 receptor agonists, which work by mimicking a natural hormone that regulates appetite and blood sugar levels. These medications have gained significant popularity in South Korea, as they have globally, for their effectiveness in promoting weight loss, but similarly approach with potential side effects and concerns about long-term sustainability. According to reports, the demand for these drugs has surged, leading to supply shortages and discussions about accessibility and affordability.
Wegovy (semaglutide), manufactured by Novo Nordisk, and Saxenda (liraglutide), also from Novo Nordisk, require a prescription and are typically intended for individuals with obesity or weight-related health conditions. The medications work by slowing down gastric emptying, increasing feelings of fullness, and reducing appetite. While effective for many, potential side effects can include nausea, vomiting, diarrhea, and constipation. The long-term effects of these medications are still being studied, and concerns about rebound weight gain upon discontinuation are common.
Potential Side Effects and the Yo-Yo Diet Cycle
The experience of 풍자 highlights the complexities of weight loss and the potential challenges associated with using medication. The “yo-yo diet” cycle, characterized by repeated cycles of weight loss and regain, can have negative impacts on both physical and mental health. Studies have shown that yo-yo dieting can be associated with increased risk of cardiovascular disease, metabolic syndrome, and psychological distress. Research published in the journal Nutrients explores the physiological and psychological consequences of weight cycling.
Experts emphasize that sustainable weight loss requires a holistic approach that includes a balanced diet, regular physical activity, and behavioral changes. Medication can be a helpful tool for some individuals, but it should be used in conjunction with lifestyle modifications and under the guidance of a healthcare professional. The sudden return of intense hunger, as described by 풍자, is a common concern among individuals discontinuing or experiencing diminished effects from GLP-1 receptor agonists.
Public Response and the Broader Conversation
풍자’s openness about her struggles has resonated with many viewers, sparking a broader conversation about the realities of weight loss and the pressures to achieve unrealistic body standards. Her video has generated significant discussion online, with many people sharing their own experiences with weight loss medications and the challenges of maintaining a healthy weight. The situation also underscores the importance of realistic expectations and the need for ongoing support and guidance throughout the weight loss journey.
Kim Do-hyun, a journalist with TV Report, has been closely following 풍자’s journey and reporting on the growing trend of weight loss medication use in South Korea. Kim Do-hyun’s reporting provides further context on the cultural and societal factors influencing weight loss trends in the country.
Looking Ahead
As of March 10, 2026, 풍자 continues to document her experiences on her YouTube channel. The next update from 풍자 is anticipated to provide further insight into how she is managing her appetite and navigating the potential challenges of maintaining her weight loss. It remains to be seen how she will address the potential side effects and the risk of rebound weight gain, but her willingness to share her journey openly is providing valuable insights for others considering similar approaches to weight management.
The increasing use of weight loss medications like Wegovy and Saxenda is likely to continue driving conversations about obesity, body image, and the role of pharmaceuticals in achieving health goals. Ongoing research and public health initiatives will be crucial in addressing these complex issues and promoting sustainable, healthy lifestyles.
What are your thoughts on the use of weight loss medications? Share your experiences and perspectives in the comments below. Don’t forget to share this article with anyone who might discover it helpful.